Zymergen Inc. – NASDAQ:ZY

Add to watchlist

$2.43

Market closed

Open in about 7 hours

-8.65%

month

+20.30%

quarter

-80.75%

year

Market Cap	N/A
Enterprise value	223.98M

P/E	-0.67
EV/Sales	15.89
EV/EBITDA	-0.70
Price/Sales	17.84
Price/Book	1.06
PEG ratio	N/A
EPS	-3.55

Revenue	14.09M
EBITDA	-316.69M
Income	-364.95M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-2589.77%
Oper. margin	-2386.51%
Gross margin	-247.35%
EBIT margin	-2386.51%
EBITDA margin	-2247.37%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Zymergen Inc. (NASDAQ:ZY): Profit margin
Sep 2021	4.08M	-98.22M	-2406.39%
Dec 2021	3.03M	-78.13M	-2571.17%
Mar 2022	4.55M	-72.11M	-1583.57%
Jun 2022	2.41M	-116.46M	-4818.7%

Zymergen Inc. (NASDAQ:ZY): Earnings per share (EPS)
2022-03-22	-0.72	-0.76
2022-05-12	-0.71	-0.7
2022-08-15	-0.74	-1.13

Zymergen Inc. (NASDAQ:ZY): Debt to assets
Sep 2021	627336000	150.52M	23.99%
Dec 2021	522396000	113.91M	21.81%
Mar 2022	618189000	274.12M	44.34%
Jun 2022	470968000	234.34M	49.76%

Zymergen Inc. (NASDAQ:ZY): Cash Flow
Sep 2021	-70.53M	-7.70M	-3.12M
Dec 2021	-64.82M	-6.17M	-37.80M
Mar 2022	-44.74M	-4.67M	303K
Jun 2022	-54.83M	-8.18M	-58.14M

Zymergen alternative data

Zymergen Inc. (NASDAQ:ZY): Employee count
Aug 2023	502
Sep 2023	502
Oct 2023	502
Nov 2023	502
Dec 2023	502
Jan 2024	502
Feb 2024	502
Mar 2024	502
Apr 2024	502
May 2024	502
Jun 2024	502
Jul 2024	502

Zymergen
Hedge Funds Holdings Q3 2022

57.84% +2.09%

of ZY is owned by hedge funds

75 +0

hedge funds hold ZY stock

59.85M +2.36M

shares is hold by hedge funds

ZY hedge funds holdings changes

Zymergen Inc. (NASDAQ:ZY): Insider trades (number of shares)
Period	Buy	Sel
Nov 2021	100000	0
Jan 2022	0	77165
Feb 2022	0	46740
Mar 2022	0	25000
Apr 2022	0	32639
May 2022	0	6288
Jun 2022	0	5751
Jul 2022	0	5721
Aug 2022	0	21425
Sep 2022	0	10606
Oct 2022	0	3786

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	3 Oct 2022	SINGH ENAKSHI officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	3,786	$2.8	$10,597
Sale	2 Sep 2022	KIM MINA officer: Chief Le..	Common Stock	3,410	$2.21	$7,536
Sale	2 Sep 2022	SINGH ENAKSHI officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	3,928	$2.21	$8,681
Sale	2 Sep 2022	SERBER ZACHARIAH director, officer: Chief Science Officer director, officer: Chief Scienc..	Common Stock	3,268	$2.21	$7,222
Sale	30 Aug 2022	SINGH ENAKSHI officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	15,365	$2.27	$34,940
Sale	2 Aug 2022	SERBER ZACHARIAH director, officer: Chief Science Officer director, officer: Chief Scienc..	Common Stock	2,966	$2.61	$7,750
Sale	2 Aug 2022	KIM MINA officer: Chief Le..	Common Stock	3,094	$2.61	$8,085
Sale	5 Jul 2022	KIM MINA officer: Chief Le..	Common Stock	2,924	$1.32	$3,866
Sale	5 Jul 2022	SERBER ZACHARIAH director, officer: Chief Science Officer director, officer: Chief Scienc..	Common Stock	2,797	$1.32	$3,698
Sale	2 Jun 2022	KIM MINA officer: Chief Le..	Common Stock	2,939	$1.68	$4,932

Status	Patent	Filling date	Issue date
Application	Application ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF 3-AMINO-4-HYDROXYBENZOIC ACID BY FERMENTATION Filling date: 10 Aug 2020 Issue date: 8 Sep 2022	10 Aug 2020	8 Sep 2022
Application	Application HTP GENOMIC ENGINEERING PLATFORM Filling date: 17 May 2022 Issue date: 1 Sep 2022	17 May 2022	1 Sep 2022
Application	Application MANIPULATION OF GENES INVOLVED IN SIGNAL TRANSDUCTION TO CONTROL FUNGAL MORPHOLOGY DURING FERMENTATION AND PRODUCTION Filling date: 21 Mar 2022 Issue date: 18 Aug 2022	21 Mar 2022	18 Aug 2022
Application	Application LABORATORY AUTOMATION SYSTEM IMPLEMENTING EFFICIENT PATH FOR MATERIAL AND LABWARE TRANSFERS Filling date: 26 Jun 2020 Issue date: 18 Aug 2022	26 Jun 2020	18 Aug 2022
Application	Application MICROBIAL ENGINEERING METHODS AND SYSTEMS FOR OPTIMIZING MICROBE FITNESS Filling date: 6 Dec 2021 Issue date: 21 Jul 2022	6 Dec 2021	21 Jul 2022
Grant	Grant Utility: HTP genomic engineering platform Filling date: 7 May 2021 Issue date: 7 Jun 2022	7 May 2021	7 Jun 2022
Application	Application ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF L-HOMOCYSTEINE BY FERMENTATION Filling date: 24 Mar 2020 Issue date: 26 May 2022	24 Mar 2020	26 May 2022
Application	Application HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS Filling date: 26 Jan 2022 Issue date: 12 May 2022	26 Jan 2022	12 May 2022
Grant	Grant Utility: Systems and methods for host cell improvement utilizing epistatic effects Filling date: 12 May 2021 Issue date: 26 Apr 2022	12 May 2021	26 Apr 2022
Grant	Grant Utility: Method for counterselection in microorganisms Filling date: 9 Aug 2021 Issue date: 12 Apr 2022	9 Aug 2021	12 Apr 2022

Zymergen
Earnings Call Transcripts

Quarter	Transcript
Q1 2022 13 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 22 Mar 2022	Q4 2021 Earnings Call Transcript
Q3 2021 3 Nov 2021	Q3 2021 Earnings Call Transcript
Q1 2021 25 May 2021	Q1 2021 Earnings Call Transcript

ZY earnings call transcripts

Zymergen
Executives

Insider	Age	Since	Compensation
Ms. Mina Kim (1974) Chief Legal Officer	51		$641,090
Mr. Aaron Kimball (1984) Chief Technology Officer	41		$453,830

Zymergen
Latest News

Friday, 13 September 2024
13:04	SEC Charges Zymergen Inc. With Misleading IPO Investors About Company's Market Potential and Sales Prospects	newsfilecorp.com
Wednesday, 19 October 2022
09:08	Ginkgo Bioworks Completes Acquisition of Zymergen	prnewswire.com
Wednesday, 24 August 2022
15:55	ZYMERGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY	businesswire.com
Monday, 22 August 2022
09:38	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY	prnewswire.com
Thursday, 11 August 2022
05:10	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GMTX, MANT, ZY, LOTZ	prnewswire.com
Wednesday, 27 July 2022
17:52	Investor Alert - The M&A Class Action Firm Announces the Investigation of Zymergen Inc. - ZY	prnewswire.com
Tuesday, 26 July 2022
02:45	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates IEA, ZY, FLAC	prnewswire.com
Monday, 25 July 2022
21:15	SHAREHOLDER ALERT: Weiss Law Investigates Infrastructure and Zymergen Inc.	prnewswire.com
14:31	Why Ginkgo Bioworks (DNA) Is Buying Zymergen For $300 Million	Pulse2
09:23	Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million	Forbes
09:11	Gingko Buys Embattled Biotech Firm Zymergen For Paltry $300 Million	Forbes
Thursday, 2 June 2022
15:34	Good Penny Stocks to Buy Now? 3 to Watch in June	PennyStocks
Monday, 23 May 2022
04:05	Zymergen: A Humbled Company With A Business On The Ropes	Seeking Alpha
Friday, 13 May 2022
12:42	Zymergen, Inc. (ZY) CEO Jay Flatley on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Thursday, 12 May 2022
19:34	Zymergen (ZY) Reports Q1 Loss, Tops Revenue Estimates	Zacks Investment Research
Thursday, 5 May 2022
16:33	Zymergen (ZY) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release	Zacks Investment Research
Thursday, 28 April 2022
12:56	10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?	PennyStocks
Wednesday, 20 April 2022
12:58	Why Shares of Zymergen Are Plunging Today	The Motley Fool
Wednesday, 13 April 2022
16:05	Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022	GlobeNewsWire
Tuesday, 22 March 2022
20:00	Zymergen, Inc. (ZY) CEO Jay Flatley on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Wednesday, 16 March 2022
16:05	Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022	GlobeNewsWire
Monday, 28 February 2022
08:00	Zymergen to Present at the 42nd Annual Cowen Healthcare Conference	GlobeNewsWire
Friday, 18 February 2022
15:33	6 Penny Stocks To Buy For Under $5 With Unusual Options Activity	PennyStocks
Thursday, 9 December 2021
09:01	Zymergen: Total Chaos	Seeking Alpha
Monday, 22 November 2021
11:57	Why Shares of Zymergen Are Skyrocketing Today	The Motley Fool
Tuesday, 19 October 2021
14:19	Why Zymergen Stock Sank Today	The Motley Fool
Wednesday, 13 October 2021
06:30	The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO	Forbes
Monday, 4 October 2021
10:00	Last Few Hours for Shareholders to Actively Participate in Zymergen, Inc. (ZY) Class Action: Bronstein, Gewirtz & Grossman, LLC	Newsfile Corp
Sunday, 3 October 2021
12:00	ZY Final Deadline Tomorrow: Rosen, A Top Ranked Law Firm, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - ZY	Newsfile Corp
11:11	Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Zymergen Inc. Investors - ZY	Newsfile Corp

Frequently Asked Questions (FAQ)

What's the price of Zymergen stock today?

One share of Zymergen stock can currently be purchased for approximately $2.43.
When is Zymergen's next earnings date?

Unfortunately, Zymergen's (ZY) next earnings date is currently unknown.
Does Zymergen pay dividends?

No, Zymergen does not pay dividends.
What is Zymergen's stock symbol?

Zymergen Inc. is traded on the NASDAQ under the ticker symbol "ZY".
What is Zymergen's primary industry?

Company operates in the Basic Materials sector and Chemicals - Specialty industry.
How do i buy shares of Zymergen?

Shares of Zymergen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Zymergen's key executives?
Zymergen's management team includes the following people:
- Ms. Mina Kim Chief Legal Officer(age: 51, pay: $641,090)
- Mr. Aaron Kimball Chief Technology Officer(age: 41, pay: $453,830)
How many employees does Zymergen have?

As Jul 2024, Zymergen employs 502 workers.
When Zymergen went public?

Zymergen Inc. is publicly traded company for more then 4 years since IPO on 22 Apr 2021.
What is Zymergen's official website?

The official website for Zymergen is zymergen.com.
Where are Zymergen's headquarters?

Zymergen is headquartered at 5980 Horton Street, EmeryVille, CA.
How can i contact Zymergen?

Zymergen's mailing address is 5980 Horton Street, EmeryVille, CA and company can be reached via phone at +41 58018073.

Zymergen Inc.

zymergen.com

Exchange:

NASDAQ

Full time employees:

502

Industry:

Chemicals - Specialty

Sector:

Basic Materials

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

+41 58018073

5980 Horton Street
EmeryVille, CA 94608

CIK: 0001645842
ISIN: US98985X1000
CUSIP: 98985X100